Drawing for EMPOWER PHARMA

USPTO serial 88262059

EMPOWER PHARMA

Reviewed by CopyMark Law Group

Reg. 7504902Status 700Registered
Filing date
Status date
Registration date
Sep 17, 2024
Examiner
BERTRAND, JOSEPH A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMPOWER PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN A YATES

JOHN A YATES PATTERSON & SHERIDAN LLP24 GREENWAY PLAZASUITE 1600HOUSTON, TX 77046

Goods and services

ClassDescriptionStatusFirst use
005Sterile prescription pharmaceuticals for human use, namely, sterile injectable pharmaceuticals, namely, compounded sterile injectable pharmaceuticals, namely, medications, vitamins, minerals, and supplements, namely, alpha-lipoic acid, ascorbic acid, bacteriostatic water, branched-chain amino acids, vitamin B, mixtures of papaverine and phentolamine, calcium gluconate, mixtures of gamma-aminobutyric acid and magnesium chloride hexahydrate and taurine and theanine, ubiquinone, cyanocobalamin, dexpanthenol, edetate disodium, urofollitropin, growth hormone releasing peptides, human chorionic gonadotropin, ipamoreline acetate, l-arginine HCl, l-carnitine, mixtures of methionine and inositol and choline chloride and cyanocobalamin, mixtures of methionine and inositol and choline chloride and l-carnitine and thiamine HCl and dexpanthenol, mixtures of methionine and inositol and choline chloride, l-lysine HCl, menotropins, methylcobalamin, nandrolone decanoate, phenylephrine HCl, progesterone, pyridoxine HCl, mixtures of papaverine and phentolamine mesylate and prostaglandin and atropine sulfate, sermoreline acetate, sodium bicarbonate, taurine, testosterone cypionate, mixtures of testosterone cypionate and testosterone propionate, testosterone enanthate, testosterone propionate, mixtures of l-arginine HCL and l-citrulline and l-ornithine HCl, and mixtures of papaverine and phentolamine mesylate and prostaglandin E1ACTIVEMar 22, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2025PRA7REGISTERED - SEC. 7 REQUEST ABANDONED—
Mar 28, 2025PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Mar 27, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 30, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 29, 2024ES7RTEAS SECTION 7 REQUEST RECEIVED—
Sep 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 29, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 26, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 26, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 26, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 5, 2024ALIEASSIGNED TO LIE—
Aug 10, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 13, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 30, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 28, 2022DOCKASSIGNED TO EXAMINER—
Apr 29, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 29, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 23, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 23, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 23, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 19, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 19, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 19, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 23, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 23, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Oct 23, 2019CNSLSUSPENSION LETTER WRITTEN—
Oct 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 16, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2019DOCKASSIGNED TO EXAMINER—
Feb 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance